Abstract
Diffuse intrinsic pontine glioma (DIPG) of childhood has a dismal prognosis. Clinical trials of new agents are vital and it is essential that the correct endpoints and disease assessments are chosen. A retrospective review of magnetic resonance imaging (MRI) scanning in a pure population of DIPG was undertaken. Baseline diagnostic MRI findings included; local tumour extension in upper medulla (74%) or midbrain (62%), metastatic disease (3%), basilar artery encasement (82%), necrosis (33%), intratumoural haemorrhage (26%), hydrocephalus (23%) and dorsal exophytic component (18%). Post-treatment MRI scans demonstrated increases in; leptomeningeal metastatic disease (16%), cystic change/necrosis (48%), enhancement (72%) and intratumoural haemorrhage (32%). Response rates were calculated according to both RECIST (4%) and WHO (24%) criteria. No MRI parameter in either the diagnostic or response scans had prognostic significance. We recommend that currently primary endpoints for DIPG clinical trials should be overall or possibly progression free survival and that new advanced functional imaging techniques should be explored as possible surrogate markers for novel therapy activity rather than conventional MRI response criteria.
Similar content being viewed by others
References
Albright AL, Guthkelch AN, Packer RJ, Price RA, Rourke LB (1986) Prognostic factors in pediatric brain-stem gliomas. J Neurosurg 65(6):751–755
Fisher PG, Breiter SN, Carson BS, Wharam MD, Williams JA, Weingart JD et al (2000) A clinicopathologic reappraisal of brain stem tumor classification. Identification of pilocystic astrocytoma and fibrillary astrocytoma as distinct entities. Cancer 89(7):1569–1576
Fischbein NJ, Prados MD, Wara W, Russo C, Edwards MS, Barkovich AJ (1996) Radiologic classification of brain stem tumors: correlation of magnetic resonance imaging appearance with clinical outcome. Pediatr Neurosurg 24(1):9–23
Zimmerman RA (1996) Neuroimaging of primary brainstem gliomas: diagnosis and course. Pediatr Neurosurg 25(1):45–53
Hargrave D, Bartels U, Bouffet E (2006) Diffuse brainstem glioma in children: critical review of clinical trials. Lancet Oncol 7(3):241–248
Freeman CR, Bourgouin PM, Sanford RA, Cohen ME, Friedman HS, Kun LE (1996) Long term survivors of childhood brain stem gliomas treated with hyperfractionated radiotherapy. Clinical characteristics and treatment related toxicities. The Pediatric Oncology Group. Cancer 77(3):555–562
Kaplan AM, Albright AL, Zimmerman RA, Rorke LB, Li H, Boyett JM et al (1996) Brainstem gliomas in children. A Children’s Cancer Group review of 119 cases. Pediatr Neurosurg 24(4):185–192
Kwon JW, Kim IO, Cheon JE, Kim WS, Moon SG, Kim TJ et al (2006) Paediatric brain-stem gliomas: MRI, FDG-PET and histological grading correlation. Pediatr Radiol 36(9):959–964
Smith RR, Zimmerman RA, Packer RJ, Hackney DB, Bilaniuk LT, Sutton LN et al (1990) Pediatric brainstem glioma. Post-radiation clinical and MR follow-up. Neuroradiology 32(4):265–271
Moghrabi A, Kerby T, Tien RD, Friedman HS (1995) Prognostic value of contrast-enhanced magnetic resonance imaging in brainstem gliomas. Pediatr Neurosurg 23(6):293–298
Gururangan S, McLaughlin CA, Brashears J, Watral MA, Provenzale J, Coleman RE et al (2006) Incidence and patterns of neuraxis metastases in children with diffuse pontine glioma. J Neurooncol 77(2):207–212
Broniscer A, Laningham FH, Kocak M, Krasin MJ, Fouladi M, Merchant TE et al (2006) Intratumoral hemorrhage among children with newly diagnosed, diffuse brainstem glioma. Cancer 106(6):1364–1371
Albright AL (1996) Diffuse brainstem tumors: when is a biopsy necessary? Pediatr Neurosurg 24(5):252–255
Cartmill M, Punt J (1999) Diffuse brain stem glioma. A review of stereotactic biopsies. Childs Nerv Syst 15(5):235–237
Albright AL, Packer RJ, Zimmerman R, Rorke LB, Boyett J, Hammond GD (1993) Magnetic resonance scans should replace biopsies for the diagnosis of diffuse brain stem gliomas: a report from the Children’s Cancer Group. Neurosurgery 33(6):1026–1029
Gilbertson RJ, Hill DA, Hernan R, Kocak M, Geyer R, Olson J et al (2003) ERBB1 is amplified and overexpressed in high-grade diffusely infiltrative pediatric brain stem glioma. Clin Cancer Res 9(10 Pt 1):3620–3624
Lassman AB, Abrey LE, Gilbert MR (2006) Response of glioblastomas to EGFR kinase inhibitors. N Engl J Med 354(5):525–526
Mellinghoff IK, Wang MY, Vivanco I, Haas-Kogan DA, Zhu S, Dia EQ et al (2005) Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors. N Engl J Med 353(19):2012–2024
Pincus DW, Richter EO, Yachnis AT, Bennett J, Bhatti MT, Smith A (2006) Brainstem stereotactic biopsy sampling in children. J Neurosurg 104(2 Suppl):108–114
Samadani U, Judy KD (2003) Stereotactic brainstem biopsy is indicated for the diagnosis of a vast array of brainstem pathology. Stereotact Funct Neurosurg 81(1–4):5–9
Hollingworth W, Medina LS, Lenkinski RE, Shibata DK, Bernal B, Zurakowski D et al (2006) A systematic literature review of magnetic resonance spectroscopy for the characterization of brain tumors. AJNR Am J Neuroradiol 27(7):1404–1411
Laprie A, Pirzkall A, Haas-Kogan DA, Cha S, Banerjee A, Le TP et al (2005) Longitudinal multivoxel MR spectroscopy study of pediatric diffuse brainstem gliomas treated with radiotherapy. Int J Radiat Oncol Biol Phys 62(1):20–31
Tzika AA, Cheng LL, Goumnerova L, Madsen JR, Zurakowski D, Astrakas LG et al (2002) Biochemical characterization of pediatric brain tumors by using in vivo and ex vivo magnetic resonance spectroscopy. J Neurosurg 96(6):1023–1031
Porto L, Hattingen E, Pilatus U, Kieslich M, Yan B, Schwabe D et al (2006) Proton magnetic resonance spectroscopy in childhood brainstem lesions. Childs Nerv Syst 23:305–314
Warren KE, Frank JA, Black JL, Hill RS, Duyn JH, Aikin AA et al (2000). Proton magnetic resonance spectroscopic imaging in children with recurrent primary brain tumors. J Clin Oncol 18(5):1020–1026
Astrakas LG, Zurakowski D, Tzika AA, Zarifi MK, Anthony DC, De Girolami U et al (2004) Noninvasive magnetic resonance spectroscopic imaging biomarkers to predict the clinical grade of pediatric brain tumors. Clin Cancer Res 10(24):8220–8228
Marcus KJ, Astrakas LG, Zurakowski D, Zarifi MK, Mintzopoulos D, Poussaint TY et al (2007) Predicting survival of children with CNS tumors using proton magnetic resonance spectroscopic imaging biomarkers. Int J Oncol 30(3):651–657
Cao Y, Tsien CI, Nagesh V, Junck L, Ten Haken R, Ross BD et al (2006) Survival prediction in high-grade gliomas by MRI perfusion before and during early stage of RT [corrected]. Int J Radiat Oncol Biol Phys 64(3):876–885
Chang YW, Yoon HK, Shin HJ, Roh HG, Cho JM (2003) MR imaging of glioblastoma in children: usefulness of diffusion/perfusion-weighted MRI and MR spectroscopy. Pediatr Radiol 33(12):836–842
Law M, Oh S, Johnson G, Babb JS, Zagzag D, Golfinos J et al (2006) Perfusion magnetic resonance imaging predicts patient outcome as an adjunct to histopathology: a second reference standard in the surgical and nonsurgical treatment of low-grade gliomas. Neurosurgery 58(6):1099–1107
Law M, Yang S, Babb JS, Knopp EA, Golfinos JG, Zagzag D et al (2004) Comparison of cerebral blood volume and vascular permeability from dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade. AJNR Am J Neuroradiol 25(5):746–755
Law M, Yang S, Wang H, Babb JS, Johnson G, Cha S et al (2003) Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging. AJNR Am J Neuroradiol 24(10):1989–1998
Bruggers CS, Friedman HS, Fuller GN, Tien RD, Marks LB, Halperin EC et al (1993) Comparison of serial PET and MRI scans in a pediatric patient with a brainstem glioma. Med Pediatr Oncol 21(4):301–306
De Witte O, Lefranc F, Levivier M, Salmon I, Brotchi J, Goldman S (2000) FDG-PET as a prognostic factor in high-grade astrocytoma. J Neurooncol 49(2):157–163
Kim S, Chung JK, Im SH, Jeong JM, Lee DS, Kim DG et al (2005) 11C-methionine PET as a prognostic marker in patients with glioma: comparison with 18F-FDG PET. Eur J Nucl Med Mol Imaging 32(1):52–59
Nishiyama Y, Yamamoto Y, Fukunaga K, Satoh K, Kunishio K, Ohkawa M (2001) Comparison of 99Tcm-MIBI with 201Tl chloride SPET in patients with malignant brain tumours. Nucl Med Commun 22(6):631–639
Pardo FS, Aronen HJ, Fitzek M, Kennedy DN, Efird J, Rosen BR et al (2004) Correlation of FDG-PET interpretation with survival in a cohort of glioma patients. Anticancer Res 24(4):2359–2365
Sasaki M, Kuwabara Y, Yoshida T, Nakagawa M, Fukumura T, Mihara F et al (1998) A comparative study of thallium-201 SPET, carbon-11 methionine PET and fluorine-18 fluorodeoxyglucose PET for the differentiation of astrocytic tumours. Eur J Nucl Med 25(9):1261–1269
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hargrave, D., Chuang, N. & Bouffet, E. Conventional MRI cannot predict survival in childhood diffuse intrinsic pontine glioma. J Neurooncol 86, 313–319 (2008). https://doi.org/10.1007/s11060-007-9473-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11060-007-9473-5